环球连续五年独家撰写钱伯斯《数字医疗》（Digital Healthcare）中国篇

Alan Zhou is the head of life sciences and healthcare practice of Global Law Office. He has a strong background in the area, routinely representing multinational corporations, well-known Chinese state-owned and private enterprises and private equity/venture capital funds. As a participant or an external counsel, he has been engaged by local authorities and industrial associations to advise on legislation and industrial standards in the life sciences and healthcare industry, including guidelines on compliance and risk control, e-healthcare, medical insurance reform and medical representative administration. His insights have been widely published at home and abroad.

Charlene Huang has in-depth experience in M&A and cross-border licence deals, especially in the healthcare and life sciences sector. She has led projects involving outbound and inbound investment, acquisition of state-owned and private equity/assets, pipeline consolidation or restructuring of multinational corporations and various licence or collaboration deals in the pharmaceutical, medical device and medical services sectors. She regularly provides support and advice on projects concerning cell therapy, gene therapy, digital healthcare, medical AI, etc. She also has in-depth experience in advising multinational companies in general corporate, cybersecurity and data management matters.

Jenny Chen is an attorney-at-law in the PRC and California in the US. She is also a certified fraud examiner at the US ACFE and is a certified (but non-practising) public accountant. She focuses her practice on compliance, government investigation, internal investigation and data security. She is well-versed in conducting investigations in connection with anti-corruption under the US FCPA and the UK Bribery Act as well as financial frauds, occupational embezzlement, self-dealing and trade secrets. She has extensive experience in cybersecurity and data compliance. She has handled multiple large-scale projects in e-discovery, cross-border data protection and security and sensitive information review.

Stephanie Wang has been actively involved in advising multinational pharmaceutical and medtech companies on their corporate governance, daily operations and compliance. She has extensive knowledge of, and experience, in the life sciences and healthcare industry and routinely advises clients on a variety of commercial agreements relating to R&D, licensing, marketing authorisations and the manufacturing, distribution and promotion of medical products. She has also worked with notable private equity institutions on investments in various pharmaceutical enterprises.

Erin Han specializes in compliance and corporate. She focuses in the pharmaceutical and healthcare industry and has extensive expertise and practical experience in healthcare services, pharmaceuticals and medical devices, and healthcare management.

Freda Wang specializes cybersecurity and data privacy protection, white-collar crime and compliance investigations, as well as general corporate legal matters.